Your Location：
Home >
Browse academic inforation >
Notice of the Drug Examination Center of the State Food and Drug Administration on the Release of the Technical Guidelines for Research of the Same Prescription (Trial) (No. 48 of 2022)
Notice of the Drug Examination Center of the State Food and Drug Administration on the Release of the Technical Guidelines for Research of the Same Prescription (Trial) (No. 48 of 2022)
Published：2022-12-28
Previous: On the seventh session of the China Association for Science and Technology outstanding scientific and technological papers public notice
Next: The first Chinese herbal compound preparation Lingguizhugan granule managed according to the list of famous ancient prescription has been approved for market